🇺🇸
SHANGHAI, Sept. 6, 2026 /PRNewswire/ — Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion….
Source: prnewswire
Country: United States